Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Coxsackievirus A21 |
| Trade Name | |
| Synonyms | CAVATAK|CVA21|V937|Gebasaxturev |
| Drug Descriptions |
CAVATAK (Coxsackievirus A21) is a naturally occuring enterovirus which infect and lysis tumor cells (PMID: 17391493, PMID: 32529026). |
| DrugClasses | |
| CAS Registry Number | 1802360-06-0 |
| NCIT ID | C61493 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Coxsackievirus A21 | Coxsackievirus A21 | 0 | 2 |
| Coxsackievirus A21 + Ipilimumab | Coxsackievirus A21 Ipilimumab | 0 | 1 |
| Coxsackievirus A21 + Pembrolizumab | Coxsackievirus A21 Pembrolizumab | 0 | 4 |